AQUA-COMMS
Aqua Comms , a leading provider of global subsea connectivity services today announced the successful launch of CeltixConnect-2 (CC-2) and North Sea Connect (NSC) as part of its ownership of the Havhingsten cable system.
CC-2 is Aqua Comms’ second unrepeated system between the key data hubs of Ireland and the UK, with diverse landings into the Isle of Man (IOM). Together with CC-1 the new system brings resilient, high fibre count, capacity connectivity between these key hubs for the Carrier, Cloud and Content markets.
NSC offers a completely new route connecting the UK and the Nordics and is a repeated cable system connecting the Stellium Data Centre at D9’s SeaEdge-1 in Newcastle, UK and Blaabjerg, Denmark which also hosts Aqua Comms’ AEC-2 Trans-Atlantic cable system.
CC-2 and NSC also combine to provide regional connectivity to Aqua Comms’ AEC-1 and AEC-2 Trans-Atlantic cables ensuring resilience and diversity between the US, Ireland, the UK and the Nordics.
Chris Bayly, CCO of Aqua Comms, commented, “The addition of these two new regional systems mark an important milestone for Aqua Comms. By connecting Ireland, the UK and the Nordics, Aqua Comms is bringing its industry-leading connectivity services to these key growth markets whilst also enhancing its Trans-Atlantic footprint and connectivity between the US and Europe”
Bayly added, “This demonstrates our continued investment in delivering services to underserved markets and I’m excited to see this continue with the rollout of AEC-3 and EMIC-1”
About Aqua Comms
Aqua Comms is a leading provider of global subsea connectivity services delivered through an extensive portfolio of owned and operated subsea systems. Aqua Comms offers connectivity networking solutions including managed capacity services, spectrum and dark fibre to the global content, cloud and carrier markets.
To learn more about Aqua Comms and its portfolio of connectivity networking solutions visit www.aquacomms.com .
In April 2021, Aqua Comms DAC was acquired by Digital 9 Infrastructure plc (D9), an LSE listed investment trust managed by Triple Point Investment Management LLP.
D9 is a digital infrastructure investment trust that has raised over US$ 1.1 billion since its IPO in March 2021, investing US$ 650 million into data centres and fibre networks. Its team has over US$ 250 billion transactional and operational experience in digital infrastructure. The number 9 in Digital 9 Infrastructure comes from the UN Sustainable Development Goal number 9, which focuses the fund on investments that bridge the digital divide by increasing connectivity globally and that improve the environmental sustainability of digital infrastructure.
To learn more about D9 visit www. https://www.d9infrastructure.com/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220325005010/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press release
The disruption generated by AI enables the acceleration and industrialisation of the creation of internal solutions and start-ups through centres of excellence in Chicago, Madrid and Tbilisi.This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the depl
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press release
Deseyne® (vifilcon C) Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia with Extended Depth of Focus (EDOF) Delivers Continuous Vision at All Distances—Redefining Presbyopia Correction The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifoc
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press release
Five-year contract to drive innovation in stimulation, intervention, digital and frac automationAgreement underscores gas as a pivotal fuel for global energy demand and a bridge to lower-carbon systems Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconve
Tabelog, Japan's Largest (*1)Restaurant Search and Reservation Service,Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press release
Experience Japan's Authentic Culinary Scene in Your Language — From Search to Reservation, All on Your SmartphoneRanked No. 1 in Downloads Among "Japanese Gourmet Search Apps" Chosen by International Travelers (*2) Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photo
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom